Proteonomix is presently forming an international network of Stem Cell Laboratories, following our proprietary Proteonomix Regenerative Translational Medicine Institute (PRTMI) business model.
These institutes focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. The mission of these Institutes is to provide a seamless transition between Proteonomix's laboratory activities and the local patient care facility. This involves development of clinical protocols, manufacturing of cellular materials for clinical use, monitoring compliance of clinical trials while participating on a global level in these processes.
|
